Insights

Home » Insights » Insights Intercept Blood System

Categories

see all
Economics 06/07/2018

The economics of Double Dose Buffy Coat Platelets

For blood centres seeking a cost-effective way to implement INTERCEPTTM pathogen inactivation, double dose buffy coat platelet production may offer a solution.

What is a double dose buffy coat platelet unit?

A platelet concentrate with sufficient platelet count to result in 2 therapeutic doses after pathogen inactivation with the INTERCEPT Blood System.

The double dose buffy coat platelet...

Ask an Expert

Do you have questions about the INTERCEPT™ Blood System, blood safety or blood transfusions? The INTERCEPT team has plenty of knowledge and expertise.

Ask an Expert

The information on this site is not country-specific, and may contain information that is outside the approved indications for the country in which you are located.
Use of INTERCEPT Plasma or Platelets is contraindicated in patients with a history or allergic response to amotosalen or psoralens. Consult instructions for use for indications, contraindications, warnings, and precautions.

Cerus, INTERCEPT and the Cerus logo are trademarks of Cerus Corporation.

© 2023 Cerus Corporation. All Rights Reserved. MKT-EN 00157 v43.0